Drug
Milademetan clinical trials
Also written RAIN-32 and DS-3032b.
- studies test it
- 9
- open now
- 0
- in phase 3
- 1
- first study started
- 2013
How studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2018 | 3 |
| 2021 | 2 |
| 2023 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 1
Rain Oncology Inc (4) · Daiichi Sankyo (3) · Daiichi Sankyo Co., Ltd. (1) · Institut Curie (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses milademetan is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or LymphomasCompletedPhase 1Daiichi SankyoNCT01877382Written as Milademetan
- Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated LiposarcomaTerminatedPhase 3Rain Oncology IncNCT04979442Written as RAIN-32
- Milademetan in Advanced/Metastatic Solid TumorsTerminatedPhase 2Rain Oncology IncNCT05012397Written as RAIN-32
- Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast CancerTerminatedPhase 2Institut CurieNCT05932667Written as Milademetan
- Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedPhase 1Daiichi Sankyo Co., Ltd.NCT03671564Written as Milademetan
- Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossWithdrawnPhase 1/2Rain Oncology IncNCT06090318Written as Milademetan
- A Study of Milademetan Administration on Cardiac Repolarization in Healthy SubjectsTerminatedPhase 1Rain Oncology IncNCT05758818Written as Milademetan
- Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)TerminatedPhase 1Daiichi SankyoNCT03552029Written as Milademetan
- Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy ParticipantsCompletedEarly Phase 1Daiichi SankyoNCT03614455Written as Milademetan
Given in every arm · 1 — milademetan is usual care beside what is tested
Codes
What other systems call milademetan · ClinicalTrials.gg INT001637
- MeSH (NLM) C000717787milademetanOne source NLM
- UNII (FDA) R3I80TLN7SMILADEMETANConfirmed FDA, NLM
- NCI Thesaurus C141432MilademetanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000717787 | milademetan | One source NLM |
| UNII (FDA) | R3I80TLN7S | MILADEMETAN | Confirmed FDA, NLM |
| NCI Thesaurus | C141432 | Milademetan | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.